H2 EBITDA collapsed to $2.9m as net debt tripled to $100.1m

Gross borrowings rose from $30.0m to $100.6m and net debt from $27.9m to $100.1m, lifting leverage to roughly 7.0x underlying EBITDA. Capex of $58.7m equated to 40.1% of revenue, up from 29.4% the prior year.

Revenue reached $146.3m versus $132.1m, although the acquisition activity introduces a basis discontinuity that complicates a clean period-on-period read. Underlying EBITDA was $14.2m for the year, but the half-year shape is the striking detail: implied H2 EBITDA was only $2.9m against H1's $11.3m, and the H2 NPAT contribution was approximately negative $3.8m. The full-year result swung from a $2.7m profit to a $2.1m loss, with the company attributing the swing to property-related items.

Operating cash flow fell 59% to $4.0m from $9.9m, and closing cash was $0.5m.

Net debt of $100.1m on $14.2m of underlying EBITDA implies roughly 7.0x leverage, against a debt-light prior position. The capital deployment is real estate – owning beds previously leased – which has longer payback, but the interest cost now sits in front of operating earnings. This matters because the cushion to absorb wage, occupancy or funding-rate shocks is materially thinner than a year ago.

Second-half operating earnings deteriorated sharply. Roughly $2.9m of H2 underlying EBITDA, after $11.3m in H1, is the most concerning single data point. This matters because the run-rate entering FY24 looks well below the growth narrative that HY23 supported, and the release does not quantify what reversed.

Working capital absorbed cash. Trade debtors rose 54.6% to $13.1m and receivable days extended 9.2 to 32.6 days. Combined with the gap between EBITDA and operating cash, this weakens the read on collection quality and amplifies the funding pressure given the $0.5m cash balance.

The release explicitly states no final dividend is proposed, leaving the 0.7cps interim as the only FY23 distribution component. Against the strong HY23 narrative the second half effectively unwound much of the earnings momentum, so the release supports a read of acquisition execution but not a clean operating progression.

The release also does not quantify when the acquired or owned-versus-leased facilities are expected to deliver steady-state earnings contribution, which is the gap that matters most given the debt now sitting against them.

With reported PBT and NPAT both negative, the cleaner cash check is OCF at $4.0m, only a small fraction of the $14.2m underlying EBITDA figure. After $58.7m of capex, pre-lease free cash flow was approximately negative $54.6m and was funded by debt drawdown rather than operating performance.

Taken together – the receivables build, lower OCF, capex-heavy investment, and step-change in borrowings – very little of the FY23 result can be characterised as durable cash generation. The economics now depend on newly-owned and acquired facilities reaching occupancy and ORA-pricing assumptions the release does not disclose, which means the investment case relies on inputs investors cannot yet test from this disclosure.

This briefing cannot assess facility-level occupancy, ORA or resident-loan inflows, or the carrying-value movements behind the property-related result, which all sit outside the supplied disclosures.